Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing

Roman Mathaes, Hanns-Christian Mahler, Yves Roggo, Joerg Huwyler, Juergen Eder, Kamila Fritsch, Tobias Posset, Silke Mohl and Alexander Streubel
PDA Journal of Pharmaceutical Science and Technology March 2016, 70 (2) 109-119; DOI: https://doi.org/10.5731/pdajpst.2015.005918
Roman Mathaes
1Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland;
6Current address: Drug Product Services, Lonza AG, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roman.mathaes@lonza.com
Hanns-Christian Mahler
1Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland;
6Current address: Drug Product Services, Lonza AG, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Roggo
2Complaints and Counterfeits, Quality Control for Commercial Bulk Products, F. Hoffmann-La Roche Ltd., Kaiseraugst, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Huwyler
3Department of Pharmaceutical Technologies, University Basel, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juergen Eder
4Manufacturing Science and Technology, Parenterals Manufacturing Kaiseraugst, F. Hoffmann-La Roche Ltd., Kaiseraugst, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamila Fritsch
4Manufacturing Science and Technology, Parenterals Manufacturing Kaiseraugst, F. Hoffmann-La Roche Ltd., Kaiseraugst, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Posset
5Production Support, Parenterals Manufacturing Mannheim, Roche Diagnostics GmbH, Mannheim, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silke Mohl
1Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Streubel
1Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters (e.g., pre-compression force, capping plate height, turntable rotating speed) contribute to the final residual seal force of a sealed container closure system and its relation to container closure integrity and other drug product quality parameters. Stopper compression measured by computer tomography correlated to residual seal force measurements.

In our studies, we used different container closure system configurations from different good manufacturing practice drug product fill & finish facilities to investigate the influence of differences in primary packaging, that is, vial size and rubber stopper design on the capping process and the capped drug product. In addition, we compared two large-scale good manufacturing practice manufacturing capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.

The capping plate to plunger distance had a major influence on the obtained residual seal force values of a sealed vial, whereas the capping pre-compression force and the turntable rotation speed showed only a minor influence on the residual seal force of a sealed vial. Capping process parameters could not easily be transferred from capping equipment of different manufacturers. However, the residual seal force tester did provide a valuable tool to compare capping performance of different capping equipment. No vial showed any leakage greater than 10−8 mbar L/s as measured by a helium mass spectrometry system, suggesting that container closure integrity was warranted in the residual seal force range tested for the tested container closure systems.

LAY ABSTRACT: Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in the literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters contribute to the final capping result.

In this study, we used different container closure system configurations from different good manufacturing process drug product fill & finish facilities to investigate the influence of the vial size and the rubber stopper design on the capping process. In addition, we compared two examples of large-scale good manufacturing process capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.

  • Capping
  • Residual seal force
  • Container closure integrity
  • process control

Footnotes

  • At the author's request, this version of the article contains a correction added on July 19, 2016: Page 113, first paragraph, line 20: the value originally posted as “10−2” has now been corrected to “10−12”.

  • Abbreviations:

    CCI
    Container closure integrity
    CCS
    Container closure system
    CT
    Computer tomography
    DP
    Drug product
    GMP
    Good manufacturing practice
    Lyo
    Lyophilization
    N
    Newton
    pCCI
    physical CCI
    RPM
    Rounds per minute
    RSF
    Residual seal force
    • © PDA, Inc. 2016
    View Full Text

    PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

    If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

    Full issue PDFs are for PDA members only.

    Note to pda.org users

    The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

    Log in using your username and password

    Forgot your user name or password?

    Log in through your institution

    You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
    If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

    Purchase access

    You may purchase access to this article. This will require you to create an account if you don't already have one.

    patientACCESS

    patientACCESS - Patients desiring access to articles

    Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

    PreviousNext
    Back to top

    In This Issue

    PDA Journal of Pharmaceutical Science and Technology: 70 (2)
    PDA Journal of Pharmaceutical Science and Technology
    Vol. 70, Issue 2
    March/April 2016
    • Table of Contents
    • Index by Author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing
    (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
    (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    5 + 5 =
    Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
    Citation Tools
    Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing
    Roman Mathaes, Hanns-Christian Mahler, Yves Roggo, Joerg Huwyler, Juergen Eder, Kamila Fritsch, Tobias Posset, Silke Mohl, Alexander Streubel
    PDA Journal of Pharmaceutical Science and Technology Mar 2016, 70 (2) 109-119; DOI: 10.5731/pdajpst.2015.005918

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing
    Roman Mathaes, Hanns-Christian Mahler, Yves Roggo, Joerg Huwyler, Juergen Eder, Kamila Fritsch, Tobias Posset, Silke Mohl, Alexander Streubel
    PDA Journal of Pharmaceutical Science and Technology Mar 2016, 70 (2) 109-119; DOI: 10.5731/pdajpst.2015.005918
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Materials and Methods
      • RSF
      • CT
      • Results
      • CT
      • Conclusion
      • Conflict of Interest Declaration
      • Footnotes
      • Abbreviations:
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • Use of a Predictive Regression Model for Estimating Hold-Up Volume for Biologic Drug Product Presentations
    • Quantifying the Vial-Capping Process: Reexamination Using Micro-Computed Tomography
    • Long-Term Study of Container Closure Integrity of Rubber-Glass Vial Systems by Multiple Methods
    • Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System
    • Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) Parenterals
    • Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and Transportation
    • Sealing Behaviour of Container Closure Systems under Frozen Storage Conditions: Nonlinear Finite Element Simulation of Serum Rubber Stoppers
    • Holistic Considerations in Optimizing a Sterile Product Package to Ensure Container Closure Integrity
    • Google Scholar

    More in this TOC Section

    • Container Closure Integrity of Vial Primary Packaging Systems under Frozen Storage Conditions: A Case Study
    • Advances in Large Volume Subcutaneous Injections: A Pilot Tolerability Study of an Innovative Needle-Free Injection Platform
    • Quantification and Stability Impact Assessment of Drop Stresses in Biologic Drug Products
    Show more Research

    Similar Articles

    Keywords

    • Capping
    • Residual seal force
    • Container closure integrity
    • Process control

    Readers

    • About
    • Table of Content Alerts/Other Alerts
    • Subscriptions
    • Terms of Use
    • Contact Editors

    Author/Reviewer Information

    • Author Resources
    • Submit Manuscript
    • Reviewers
    • Contact Editors

    Parenteral Drug Association, Inc.

    • About
    • Advertising/Sponsorships
    • Events
    • PDA Bookstore
    • Press Releases

    © 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

    Powered by HighWire